Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

44 results about "Ginsenoside Rd" patented technology

Bacteroides fragilis capable of converting ginsenoside Rb1 and ginsenoside Rd to obtain rare saponin aescin XVII and ginsenoside F2 and application of bacteroides fragilis

The invention discloses bacteroides fragilis capable of converting ginsenoside Rb1 and ginsenoside Rd to obtain rare saponin aescilloside XVII and ginsenoside F2 and application of the bacteroides fragilis CMLF03. The bacteroides fragilis CMLF03 is preserved in China General Microbiological Culture Collection Center, the preservation address is No.3, Yard 1, Beichen West Road, Chaoyang District, Beijing, and the preservation number is CGMCC NO. The preservation date is January 25, 2024, and the preservation number is CGMCC (China General Microbiological Culture Collection Center) NO.41094. The invention solves the problem of low conversion rate of the existing method for converting ginsenoside into rare ginsenoside. The bacteroides fragilis CMLF03 disclosed by the invention can be used for converting ginsenoside Rb1 and ginsenoside Rd to obtain rare saponin aescin XVII and ginsenoside F2.
Owner:YUNNAN NORMAL UNIV

Glycosidase and application thereof in preparation of ginsenoside Rd

The invention discloses glycosidase and application of the glycosidase in preparation of ginsenoside Rd. The amino acid sequence of the glycosidase comprises a sequence as shown in SEQ ID NO. 1. The glycosidase catalyzes a complex feed liquid containing ginsenoside Rb1, the ginsenoside Rd is prepared through conversion in a neutral non-buffer system, the enzymatic activity is good, the process is simple, the reaction condition is mild, the conversion rate of the ginsenoside Rd can reach 71% or above, and the glycosidase is suitable for large-scale preparation and wide in application prospect.
Owner:QILU UNIVERSITY OF TECHNOLOGY (SHANDONG ACADEMY OF SCIENCES)

Immunoregulation hydrogel based on ginsenoside Rd, preparation method and application

The invention discloses immunoregulation hydrogel based on ginsenoside Rd, a preparation method and application, and relates to the technical field of biomedical materials and hydrogels. The hydrogel is prepared by taking natural polysaccharides modified by phenylboronic acid groups, derivatives of the natural polysaccharides and methacrylic anhydride modified protein biopolymers as biological matrix materials; ginsenoside Rd is used as a bioactive functional component, and polyvinyl alcohol is used as a cross-linking agent; a first dynamic reversible cross-linked network is formed through chemical cross-linking, and is endowed with injectability, self-healing property and glucose responsiveness; ginsenoside Rd is taken as a main raw material and then subjected to addition polymerization reaction under the irradiation of a photoinitiator and light, a second static covalent cross-linked network is formed, mechanical strength and structural stability are given to the system, in addition, ginsenoside Rd is loaded in the system through boric acid ester bonds, and the slow-release effect is achieved. The problems of stability and bioavailability during local application of the Chinese herbal medicine extract are solved, and healing of chronic and serious wounds can be more effectively promoted.
Owner:JILIN UNIV FIRST HOSPITAL

Detection method of ginsenoside content and its application

ActiveCN116660392BComponent separationPseudoginsenoside F11Charged aerosol detector
The present invention relates to the technical field of determination of ingredients in Chinese patent medicines, and in particular to a method for detecting ginsenoside content and an application thereof. The present invention utilizes a multiple heart-cutting two-dimensional liquid chromatography tandem charged aerosol detector method to detect the content of ginsenosides including notoginsenoside R1, ginsenoside Rg1, ginsenoside Re, 24(R)-pseudoginsenoside F11, ginsenoside Rf, ginsenoside Ra2, ginsenoside Rb1, ginsenoside Rg2, ginsenoside Rh1, ginsenoside Rc, ginsenoside Ro, ginsenoside Rb2, ginsenoside Rb3, ginsenoside Rd, ginsenoside Rg3(S), and ginsenoside Rg3(R). The method has the advantages of accuracy, high sensitivity, and strong specificity, is suitable for determining the content of ginsenosides in different Chinese patent medicines containing Panax genus Chinese medicines, and can be used reliably, comprehensively, and accurately for quality control of ginsenosides in Chinese patent medicines containing Panax genus Chinese medicines.
Owner:TIANJIN UNIV OF TRADITIONAL CHINESE MEDICINE

Beta-glucosaccharase-producing Dubocissima Newtoniensis TZF-001 and application thereof in preparation of ginsenoside through fermentation and conversion of Dubocissima Newtoniensis TZF-001

The invention discloses Dubosiella Newyorkens TZF-001 capable of producing beta-glucosidase and application of the Dubosiella Newyorkens TZF-001 in preparation of ginsenoside through fermentation and conversion, and belongs to the field of probiotic fermentation. The Dubosiella Newyorkens TZF-001 is preserved in the China Center for Type Culture Collection on December 15, 2025, and the preservation number of the Dubosiella Newyorkens TZF-001 is CCTCC (China Center for Type Culture Collection) NO: M20252889. According to the invention, ginsenoside Rb1 is used as a raw material, and Dubosiella Newyorkens TZF-001 with high yield of beta-glucosidase is used for fermentation and conversion of ginsenoside so as to prepare ginsenoside Rd. The ginsenoside Rb1 can be completely converted into Rd after fermentation, the dependence of a traditional method on acid-base hydrolysis, high temperature and high pressure and steam treatment is avoided, the reaction condition is mild, and the method has the advantages of being environmentally friendly, low in cost, high in product purity and the like. The method opens up a brand new technical path for green and low-cost preparation of ginsenoside Rd, and has remarkable innovativeness and popularization value in the field of industrialization of active ingredients of natural medicines.
Owner:JILIN AGRICULTURAL UNIV

Method for rapidly preparing high-purity ginsenoside Rd by utilizing enzyme reaction membrane separation coupling technology

The invention provides a method for rapidly preparing high-purity ginsenoside Rd by utilizing an enzyme reaction membrane separation coupling technology, and belongs to the field of medicine preparation. The method comprises the step of converting ginsenoside Rb1 into ginsenoside Rd by adopting a biological catalytic membrane fixed with beta-glucosidase. According to the method, ginsenoside Rb1 can be continuously converted into ginsenoside Rd, the conversion rate is high, enzyme can be recycled for a long time, high catalytic activity is reserved, and the production cost is remarkably reduced.
Owner:NANJING UNIV OF TRADITIONAL CHINESE MEDICINE

A ginsenoside pharmaceutical composition having tyrosinase inhibitory activity and use thereof

PendingCN122097179ACosmetic preparationsToilet preparationsTyrosineGinsenoside Rd
The present application relates to a ginsenoside composition for inhibiting tyrosinase activity, which comprises any two or any three of ginsenoside Rd, ginsenoside Re or ginsenoside Rf. Ginsenoside Rf can be used as a synergistic molecule of ginsenoside Rd and Re, and can significantly enhance the inhibitory ability of tyrosinase activity through synergistic effect, thereby reducing the synthesis and secretion of melanin.
Owner:YANBIAN UNIV

A composition containing arctiopolysaccharide for reducing blood sugar of type 2 diabetes patients and its preparation method and application

The application discloses a composition containing burdock polysaccharide for reducing blood sugar of type 2 diabetes patients and a preparation method and application thereof, and belongs to the technical field of medicine and food. The composition contains burdock polysaccharide, chitooligosaccharide, chlorogenic acid, epicatechin, resveratrol, ginsenoside Rd, and vitamin D, vitamin B1, vitamin B6, vitamin B12, magnesium glycinate and thaumatin protein. The application takes burdock polysaccharide as a core long-acting component, takes chitooligosaccharide as a short-acting synergistic component, constructs a long-short-acting synergistic blood sugar reducing system, and realizes the organic combination of rapid blood sugar reduction and stable blood sugar control. Experiments show that the composition can significantly reduce the fasting blood sugar of type 2 diabetes model rats, improve insulin resistance and glucose tolerance, reduce blood lipid and inflammatory factor levels, and reduce oxidative stress damage. The alpha-glucosidase inhibitory activity and in-vivo comprehensive blood sugar reducing effect of the composition are better than those of single burdock polysaccharide, and the composition has good taste and is suitable for long-term use of diabetes patients.
Owner:BODE BIOTECHNOLOGY (XIANGTAN) CO LTD +1

Method for extracting ginsenosides Rb1 and Rd from pseudo-ginseng

PendingCN120774986AGlycoside steroidsGinsenoside RdGradient elution
The invention discloses a method for extracting ginsenosides Rb1 and Rd from pseudo-ginseng. The method comprises the following steps: step 1, extracting raw materials; step 2, recovering ethanol; step 3, preparing crude extraction column loading liquid; step 4, crude extraction; step 5, re-dissolving; step 6, separating a single component; step 7, refining a single component of ginsenoside Rb1; and step 8, refining a single component of ginsenoside Rd. According to the method disclosed by the invention, the non-polar macroporous adsorption resin and the moderately polar macroporous adsorption resin are combined for use, gradient elution is performed, and a high-content and batch-level single-component product can be obtained; on the basis, a high-content product is further obtained through the steps of crystallization and chromatography. The method disclosed by the invention is easy to operate and implement, can be repeatedly used and is relatively high in yield.
Owner:AMICOGEN CHINA BIOPHARM CO LTD

A beta-glucosidase ge000505 for saponin conversion and a preparation method and application thereof

The application discloses a kind of β-glucosidase GE000505 for saponin conversion and its preparation method and application, belong to biotechnology field, the amino acid sequence of the β-glucosidase GE000505 as shown in SEQ ID NO.1, it is encoded by the gene with nucleotide sequence as shown in SEQ ID NO.2.This β-glucosidase GE000505 of the application can convert high content ginseng and sanchi saponin into rare saponin R2, Rg3, Rg2 and Rh1, can convert sanchi saponin R1 into R2 entirely, convert ginsenoside Rd into Rg3 entirely, convert ginsenoside Re into Rg2 entirely, convert ginsenoside Rg1 into Rh1 entirely, convert ginsenoside F1 into aPPT entirely, convert ginsenoside F2 into aPPD entirely, solve the problem that existing β-glucosidase is not resistant to alcohol in the conversion of ginsenoside.
Owner:KUNMING MEDICAL UNIVERSITY +1

A method for quality analysis of ginseng medicinal materials

The present application relates to the technical field of compound analysis, and in particular to a quality analysis method of ginseng medicinal materials, comprising the following steps: S100, preparation of a control solution: taking ginsenoside Rg1 control product, ginsenoside Re control product, ginsenoside Rf control product, ginsenoside Rb1 control product, ginsenoside Rc control product, ginsenoside Rb2 control product, ginsenoside Rd control product, 3-O-feruloylquinic acid control product, 4-coumaric acid control product, 8-O-4 / 8-O-4 dehydrogenated tri-ferulic acid control product, and adding methanol to prepare a mixed solution, and shaking to obtain the control solution. The present application synchronously monitors two components of saponins and phenolic acids under one detection method, monitors ten component contents of seven saponin components and three polyphenol components, obtains characteristic spectra of saponin components and polyphenol components, and the monitoring quality is more comprehensive and efficient.
Owner:HUNAN TIANJIN PHARMA

Method for constructing fingerprint spectrum of styptic capsule and application of styptic capsule in quality detection

PendingCN121830950AComponent separationCaffeic acidGinsenoside Rd
The invention discloses a construction method of a finger-print spectrum of a styptic capsule and application of the styptic capsule in quality detection, and belongs to the field of Chinese patent medicine detection. The method comprises the following steps: firstly, adding 80% methanol solution into contents of different batches of Xuezhenning capsules for extraction to prepare Xuezhenning capsule test solution; the method comprises the following steps: taking ginsenoside Rg1, notoginsenoside R2, ginsenoside Rd, caffeic acid, isorhamnetin, verbascoside, aesculetin, ferulic acid, rutin and quercetin as reference substances, and preparing a reference substance solution; respectively injecting the test solution and the reference solution into a high performance liquid chromatograph to obtain corresponding chromatograms; performing similarity analysis on the chromatogram of the test solution; and finally, according to the chromatogram of the test solution and the chromatogram of the reference substance solution, combining a total ion chromatogram obtained by the high-resolution mass spectrum and a mass spectrum result map of the chemical components to construct the fingerprint spectrum of the styptic Ning capsule. The method can be used for simultaneously detecting 10 components in the haemostatic Ning capsule, and can be used for accurately, clearly and objectively evaluating the quality of the haemostatic Ning capsule.
Owner:SHAANXI UNIV OF SCI & TECH

Group of UDP-glycosyltransferase for catalyzing carbohydrate chain elongation and application thereof

ActiveUS12356911B2TransferasesFermentationGinsenoside RdPyran
The present invention relates to a group of glycosyltransferase, and an application thereof. Specifically, provided is using glycosyltransferase GT29-32, GT29-33, GT29-34, GT29-4, GT29-5, GT29-7, GT29-9, GT29-11, GT29-13, GT29-17, GT29-18, GT29-19, GT29-20, GT29-21, GT29-22, GT29-23, GT29-24, GT29-25, GT29-36, GT29-37, GT29-42, GT29-43, GT29-45, GT29-46, PNUGT29-1, PNUGT29-2, PNUGT29-3, PNUGT29-4, PNUGT29-5, PNUGT29-6, PNUGT29-7, PNUGT29-8, PNUGT29-9, PNUGT29-14, and PNUGT29-15, as well as derived polypeptides thereof to catalyze the first glycosyl at position C-20, the first glycosyl at position C-6, and the first glycosyl at position C-3 of a tetracyclic triterpene compound substrate to elongate a carbohydrate chain, thereby obtaining a catalytic reaction of ginsenoside products such as ginsenoside Rg3, ginsenoside Rd, ginseno-side Rb 1, ginsenoside Rb3, saponin DMGG, saponin DMGX, gypenoside LXXV, gypenoside XVII, gypenoside XIII, gypenoside IX, notoginsenoside U, and notoginsenoside R1, notoginsenoside R2, notoginsenoside R3, 3-0-13-(D-xylopyranosyl)-13-(D-glucopyra-nosyl)-PPD, 3-0-13-(D-xylopyranosyl)-13-(D-glucopyranosyl)-CK, 20-O-Glucosylginsenoside Rf, and Ginsenoside F3. Glycosyltrans-ferase in the present invention can further be applied to construction of artificially synthesized ginsenoside, novel ginsenoside, and derivatives thereof.
Owner:GSYNBIOT (SHANGHAI) CO LTD

Novel enzymatic preparation method of ginsenoside Rd

PendingCN121874297ABacteriaMicroorganism based processesActinomadura rayongensisGinsenoside Rd
The invention discloses a method for preparing ginsenoside Rd through catalysis of L-arabinopyranosidase, which comprises the following steps: taking ginsenoside Rb1 as a substrate, and catalyzing the substrate to be hydrolyzed by using the L-arabinopyranosidase (Uniprot ID (Identity) accession number A0A6I4WC78) from Actinomadura rayonensis) or a mutant of the L-arabinopyranosidase so as to obtain the ginsenoside Rd. According to the method, the high-concentration ginsenoside Rb1 can be efficiently converted under the condition of high-concentration methanol, and industrial production of ginsenoside Rd is promoted.
Owner:SHANGHAI XINHETIDE BIOTECHNOLOGY CO LTD

Method for catalytically synthesizing ginsenoside Rd by immobilized enzyme

PendingCN120966942AImmobilised enzymesFermentationAlgluceraseGinsenoside Rd
The invention discloses a method for catalytically synthesizing ginsenoside Rd by an immobilized enzyme. The method comprises the following steps: adsorbing and fixing beta-glucosidase on a carrier UiO-66-OH to prepare the immobilized enzyme; the ginsenoside Rb1, the ginsenoside Rb2 and the ginsenoside Rb3 are catalyzed by the immobilized enzyme to be converted into the ginsenoside Rd, and the immobilized enzyme shows relatively good stability and can be recycled; the CB-gluu-coated UiO-66-OH obtained by the method disclosed by the invention can be used for efficiently converting ginsenoside Rb1, Rb2 and Rb3 into ginsenoside Rd, and the immobilized enzyme still keeps 100% of activity after being repeatedly used for 8 times.
Owner:KUNMING UNIV OF SCI & TECH

Antioxidant compositions and their use in nucleic acid detection

Antioxidant compositions and their use in nucleic acid detection. Relates to an antioxidant composition, a reagent containing the composition, a kit containing the composition or the reagent, application of the composition or the reagent as a nucleic acid protective agent in nucleic acid detection and a nucleic acid detection method. The antioxidant composition comprises the following components: a saponin compound which is selected from one or more of notoginsenoside R1, ginsenoside Rg1, ginsenoside Rd, ginsenoside Rb2, ginsenoside Rb3, ginsenoside Rc, ginsenoside Rf and ginsenoside Re; glycyrrhizic acid, salt of glycyrrhizic acid or hydrate of salt of glycyrrhizic acid; and 5 '-adenosine monophosphate or a salt thereof, or carnosine.
Owner:MGI TECH CO LTD

Construction method of characteristic chromatogram of traditional Chinese medicine compound preparation for treating senile dementia

PendingCN122084811AComponent separationDiseaseAsarone
The invention relates to the technical field of traditional Chinese medicine analysis, in particular to a construction method of a characteristic spectrum of a traditional Chinese medicine compound preparation for treating senile dementia. The method is creatively characterized in that detection of characteristic peaks is realized through extraction, preparation and purification of an extract and specific gradient selection under a specific mobile phase condition. According to the method, seven chemical components in the traditional Chinese medicine compound preparation can be analyzed, seven characteristic peaks including epimedin C, ginsenoside Rd, pachymic acid, dehydrotumuloic acid, alpha-asarone, polygala mountain ketone III and tenuigenin are identified, verification research on specificity, precision, repeatability and stability is carried out on the method, and it is proved that the method is accurate and reliable. The technical means is used as a method for overall evaluation of the traditional Chinese medicine compound preparation, and a quality control system of the traditional Chinese medicine compound preparation is comprehensively improved.
Owner:WUYUAN MATERIA MEDICA (SHANDONG) HEALTH TECH CO LTD +1

Quality analysis method of ginseng medicinal material

The invention relates to the technical field of compound analysis, in particular to a quality analysis method of a ginseng medicinal material. Comprising the following steps: S100, preparation of a reference substance solution: taking a proper amount of a ginsenoside Rg1 reference substance, a ginsenoside Re reference substance, a ginsenoside Rf reference substance, a ginsenoside Rb1 reference substance, a ginsenoside Rc reference substance, a ginsenoside Rb2 reference substance, a ginsenoside Rd reference substance, a 3-O-feruloylquinic acid reference substance, a 4-coumaric acid reference substance and an 8-O-4 / 8-O-4 dehydrotriferulic acid reference substance; and adding methanol to prepare a mixed solution, and uniformly shaking. According to the method, the saponin and phenolic acid components are synchronously monitored under one detection method, the contents of ten components including seven saponin components and three polyphenol components are monitored, the specific chromatograms of the saponin components and the polyphenol components are obtained, and the monitoring quality is more comprehensive and efficient.
Owner:HUNAN TIANJIN PHARMA

Multi-component quantitative analysis method for anti-aging tablets

The application provides a multi-component quantitative analysis method of anti-aging tablets, acetonitrile-0.1% formic acid aqueous solution is used as a mobile phase, an HSS T3 chromatographic column is used for target compound separation, and 13 active components in the anti-aging tablets are simultaneously determined in an MRM mode by using an electrospray ionization triple quadrupole mass spectrometer, the linear range of the 13 active components is 0.4-100 ng / mL, the linear range of ginsenoside Rb1, ginsenoside Rb2, ginsenoside Rc, ginsenoside Rd, ginsenoside Re, ginsenoside Rf and ginsenoside Rg1 is 4-1000 ng / mL, the method has high sensitivity, strong specificity and good reproducibility, and realizes simultaneous quantitative analysis of the 13 active components in the anti-aging tablets.
Owner:TIANJIN UNIV OF TRADITIONAL CHINESE MEDICINE +1

Application of Burkholderia sp. WJ-02 in conversion of ginsenoside and conversion method of Burkholderia sp. WJ-02

The invention belongs to the technical field of microbial bioconversion, and particularly relates to application of Burkholderia sp. WJ-02 in ginsenoside conversion and a conversion method, and the Burkholderia sp. WJ-02 can convert ginsenoside Rb3 into ginsenoside Rd and rare ginsenoside F2. The Burkholderia sp. WJ-02 is separated from rhizosphere soil of American ginseng, the Burkholderia sp. WJ-02 can efficiently and selectively convert main ginsenoside Rb3 into ginsenoside Rd and rare ginsenoside F2 by taking American ginseng stem and leaf saponin as a substrate, and conversion target products are concentrated, so that subsequent purification is facilitated.
Owner:WEIFANG MEDICAL UNIV

Bacillus lactis capable of transforming ginsenoside and cassia glycoside and application of the bacillus lactis in reducing fat and relieving fatty liver

PendingCN122256175ABroad enzymatic activityIncrease contentOrganic active ingredientsBacteriaGinsenoside RdLipid lowering
The application discloses a plant lactobacillus gasseri strain capable of transforming ginsenoside and cassia glycoside, and application of the strain in lipid reduction and alleviation of fatty liver, and belongs to the fields of microbial technology, medicine and functional food. The core feature of the strain is that the strain can not only transform ginsenoside Rb1 into ginsenoside Rd with higher activity, but also transform cassia glycoside into cassia glycoside base, thereby improving the efficacy. The animal experiment proves that the strain and the corresponding substrate are combined to play a better role in lipid reduction and liver protection: the serum total cholesterol and triglyceride levels of high-fat diet mice can be effectively reduced, and the liver weight, liver lipid deposition and liver tissue fatty degeneration can be reduced and improved. The strain provides a new core strain and technical scheme for developing microecological preparations for preventing and / or assisting in treating hyperlipidemia, non-alcoholic fatty liver and other metabolic diseases.
Owner:WUXI INSTITUTE FOR SPECIALIZED NUTRITION & HEALTH CO LTD

Compound melanterite pill specific chromatogram and construction method and quality detection method thereof

The invention discloses a compound melanterite pill specific chromatogram and a construction method and a quality detection method thereof, and belongs to the field of Chinese patent medicine detection. Taking different batches of compound melanterite pills as test articles to prepare a compound melanterite pill test article solution; the method comprises the following steps: taking gallic acid, ginsenoside Rg1, procyanidine B2, cinnamic acid, coumarin, ginsenoside Rh1, cinnamyl alcohol, cinnamaldehyde, arachidonic acid, epicatechin, 2-methoxycinnamic acid, ginsenoside Rb1, ginsenoside Rd, betulinic acid and 5-hydroxymethylfurfural as reference substances to prepare a single reference substance solution; performing chromatographic analysis on the compound melanterite pill test solution and the single reference substance solution, and recording chromatograms; carrying out similarity analysis; and constructing the characteristic chromatogram of the compound melanterite pill according to the chromatogram of the test solution of the compound melanterite pill and the chromatogram of the single reference substance solution in combination with the total ion chromatogram obtained by the high-resolution mass spectrum and the mass spectrum result map of the chemical components. The method can accurately, clearly and objectively evaluate the quality of the compound melanterite pill.
Owner:SHAANXI UNIV OF SCI & TECH

A strain of *Duboscirella nymphoides* TZF-001 producing β-glucosidase and its application in the fermentation and conversion of ginsenosides.

A strain of *Duboscirella nystatin* that produces β-glucosidase ( Dubosiella newyorkensis TZF-001 and its application in the fermentation and conversion of ginsenosides belong to the field of probiotic fermentation. This *Duboscirella nystatin* (TZF-001) and its application in the fermentation and conversion of ginsenosides belong to the field of probiotic fermentation. Dubosiella newyorkensis TZF-001 was deposited at the China Center for Type Culture Collection on December 15, 2025, with accession number CCTCC NO: M20252889. This invention uses ginsenoside Rb1 as a raw material and utilizes *Duboscirella nystatin*, a bacterium that produces high levels of β-glucosidase. Dubosiella newyorkensis The TZF-001 fermentation method converts ginsenosides (Rb1) to ginsenoside Rd. After fermentation, ginsenoside Rb1 can be completely converted to Rd. This invention avoids the dependence on acid-base hydrolysis, high temperature and pressure, and steam treatment in traditional methods. Its reaction conditions are mild, and it boasts advantages such as environmental friendliness, low cost, and high product purity. This opens up a new technological path for the green and low-cost preparation of ginsenoside Rd, and has significant innovative and promotional value in the industrialization of natural drug active ingredients.
Owner:JILIN AGRICULTURAL UNIV

SNP (Single Nucleotide Polymorphism) molecular marker related to content of ginsenoside Rd in panax notoginseng and application

The invention discloses an SNP molecular marker related to the content of ginsenoside Rd in panax notoginseng and application, and belongs to the technical field of molecular genetic breeding, the SNP molecular marker is SNP8-10420362 and is located at the 10420362th basic group of Chr8 chromosome, and the mutation type of the SNP molecular marker is T / A. The invention further discloses a method for detecting the content of ginsenoside Rd in panax notoginseng. The KASP primer combination developed by the invention can accurately distinguish pseudo-ginseng with high ginsenoside Rd content from pseudo-ginseng with low ginsenoside Rd content, can be applied to pseudo-ginseng molecular-assisted marker breeding and shorten the breeding period of a new variety, and is relatively low in detection cost, free from environmental limitation, high in detection result accuracy and easy to repeat. The method has important theoretical and practical guiding significance for accelerating the genetic improvement process of panax notoginseng breeding with high ginsenoside Rd content and improving the breeding selection efficiency.
Owner:WENSHAN UNIV

Beta-glucosidase BglSK mutant and application thereof

The invention discloses a beta-glucosidase BglSK mutant and an application of the beta-glucosidase BglSK mutant. The BglSK mutant is mutated by taking an amino acid sequence as shown in SEQ ID NO. 1 as a benchmark. According to the beta-glucosidase BglSK mutant disclosed by the invention, one or more amino acid residues are introduced at a specific site for substitution, so that the thermal stability and / or catalytic activity of beta-glucosidase are / is remarkably improved; in addition, ginsenoside Rd or analogues thereof can be efficiently catalyzed, and rare ginsenoside F2 and / or rare ginsenoside CK can be directionally generated. According to the beta-glucosidase BglSK mutant disclosed by the invention, large-scale production of rare ginsenoside is successfully realized, and the beta-glucosidase BglSK mutant has huge industrial application prospect and value.
Owner:GUANGDONG MIDEMENG SWEET CELL TECHNOLOGY CO LTD

Anti-inflammatory use of ginsenoside rd

The present invention discloses a novel application of ginsenoside Rd in preparation of a drug for relieving or / and treating inflammations and health food / medicinal and edible food / functional food / dietary supplement. Tests prove that ginsenoside Rd has a remarkable curative effect on inflammations, takes effect quickly, has a better effect than Dexamethasone, is suitable for both acute inflammations such as influenza virus pneumonia, novel coronavirus pneumonia and acute lung injury inflammations, and chronic inflammations such as chronic obstructive pneumonia and chronic asthmatic airway inflammations, and is regarded as a new drug source for treating acute and chronic inflammations and complications thereof.
Owner:FU LI

Fusion enzyme for producing rare ginsenoside Rh2 as well as preparation method and application of fusion enzyme

PendingCN121427885ALiquid crystal compositionsBacteriaAlgluceraseGinsenoside Rh2
The invention belongs to the technical field of enzyme engineering, and discloses a fusion enzyme for producing rare ginsenoside Rh2 and a preparation method and application thereof. The active part of the fusion enzyme is obtained by sequentially connecting beta-glucosidase Bglpm, a connecting peptide and beta-glucosidase Bgp1. Two enzymes are fused into one enzyme molecule through a gene fusion technology, and the fusion enzyme obtained after screening and optimization effectively improves the catalytic efficiency of the enzyme, so that the reaction rate of converting ginsenoside Rd into rare ginsenoside Rh2 is remarkably improved, the fusion enzyme simplifies the catalytic process, reduces the reaction steps and reaction time, and is suitable for industrial production. And the production efficiency can be improved and the production cost can be reduced.
Owner:SOUTH CHINA UNIV OF TECH

Preparation method and application of corn protein particles selectively embedding ginsenoside Rd

PendingCN122643261AFreeze-dryingGinsenoside Rd
The present application relates to the field of active substance embedding delivery technology, and particularly relates to a preparation method and application of corn protein particles for selectively embedding ginsenoside Rd. The preparation method comprises the following steps: (1) dissolving zein in an ethanol solution; (2) adding total ginsenoside to the zein solution; (3) preparing casein buffer, and quickly adding the casein buffer to the mixture; (4) removing ethanol by using a rotary evaporation method; (5) filtering the nanoparticle dispersion; and (6) freeze-drying. The prior art needs to use high-purity ginsenoside Rd monomers as embedding raw materials, and the direct embedding of crude extracts has no selectivity, and the product components are mixed and the quality is uncontrollable. The present application uses the specific binding ability of zein to ginsenoside Rd to selectively enrich ginsenoside Rd from a mixture containing multiple saponins, and the proportion of Rd in the embedded total saponins can reach more than 90%. The overall preparation cost is significantly reduced, and the production is suitable for large-scale industrialization.
Owner:INST OF URBAN AGRI CHINESE ACADEMY OF AGRI SCI

Application of burkholderia WJ-02 in transforming ginsenosides and transformation method

The application belongs to the technical field of microbial bioconversion, and particularly relates to application of Burkholderia WJ-02 in conversion of ginsenoside and a conversion method, wherein the Burkholderia WJ-02 can convert ginsenoside Rb3 into ginsenoside Rd and rare ginsenoside F2. The Burkholderia WJ-02 is obtained by being separated from rhizosphere soil of American ginseng, the strain can efficiently and selectively convert ginsenoside Rb3 into ginsenoside Rd and rare ginsenoside F2 with American ginseng stem and leaf saponin as a substrate, and the conversion target product is concentrated, so that subsequent purification is facilitated.
Owner:WEIFANG MEDICAL UNIV

Method for detecting various rare ginsenosides in health food by quantitative analysis of multi-components by single marker

PendingCN120891114AComponent separationBiotechnologyGinsenoside Rd
The invention provides a method for detecting multiple rare ginsenosides in health-care food by quantitative analysis of multi-components by single marker (QAM), and solves the problem of insufficient rare ginsenoside reference substances when the rare ginsenosides are detected by an external standard method. Ginsenoside Rd is used as an internal reference substance for quantitative analysis of multiple components by single marker, and relative correction factors between the ginsenoside Rd and ginsenoside Rg2, ginsenoside Rh1, ginsenoside F2, ginsenoside 20-(S)-Rg3, ginsenoside Rk3, ginsenoside Rk1, ginsenoside Rh4, ginsenoside 20-(R)-Rg3 and ginsenoside Rg5 are established. And calculating the content of each rare ginsenoside in the health food through the relative correction factor. The method has the advantages of high practicability, strong operability, cost saving and the like.
Owner:SHANDONG MINGREN FURUIDA PHARMA